These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 12063176)
41. Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution. Dunn SE; Brindley A; Davis SS; Davies MC; Illum L Pharm Res; 1994 Jul; 11(7):1016-22. PubMed ID: 7937542 [TBL] [Abstract][Full Text] [Related]
42. Adsorption and viscoelastic properties of fractionated mucin (BSM) and bovine serum albumin (BSA) studied with quartz crystal microbalance (QCM-D). Feiler AA; Sahlholm A; Sandberg T; Caldwell KD J Colloid Interface Sci; 2007 Nov; 315(2):475-81. PubMed ID: 17706239 [TBL] [Abstract][Full Text] [Related]
43. Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Blunk T; Hochstrasser DF; Sanchez JC; Müller BW; Müller RH Electrophoresis; 1993 Dec; 14(12):1382-7. PubMed ID: 8137807 [TBL] [Abstract][Full Text] [Related]
44. Biodegradable poly(ethylene carbonate) nanoparticles as a promising drug delivery system with "stealth" potential. Bege N; Renette T; Jansch M; Reul R; Merkel O; Petersen H; Curdy C; Müller RH; Kissel T Macromol Biosci; 2011 Jul; 11(7):897-904. PubMed ID: 21472988 [TBL] [Abstract][Full Text] [Related]
45. Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles. Huang M; Wu W; Qian J; Wan DJ; Wei XL; Zhu JH Acta Pharmacol Sin; 2005 Dec; 26(12):1512-8. PubMed ID: 16297352 [TBL] [Abstract][Full Text] [Related]
46. Effect of surface energy of solid surfaces on the micro- and macroscopic properties of adsorbed BSA and lysozyme. Sharma I; Pattanayek SK Biophys Chem; 2017 Jul; 226():14-22. PubMed ID: 28433534 [TBL] [Abstract][Full Text] [Related]
47. Phenylalanine containing hydrophobic nanospheres for antibody purification. Türkmen D; Denizli A; Oztürk N; Akgöl S; Elkak A Biotechnol Prog; 2008; 24(6):1297-303. PubMed ID: 19194944 [TBL] [Abstract][Full Text] [Related]
48. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain. Parikh T; Bommana MM; Squillante E Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957 [TBL] [Abstract][Full Text] [Related]
49. Disassembly of Nanospheres with a PEG Shell upon Adsorption onto PEGylated Substrates. Patel A; Lima MRN; Cho HY; Lee KB; Murthy NS; Kohn J Langmuir; 2020 Jan; 36(1):232-241. PubMed ID: 31825622 [TBL] [Abstract][Full Text] [Related]
50. Character of adsorbed bovine serum albumin from adsorption enthalpies. Filisko FE; Malladi D; Barenberg S Biomaterials; 1986 Sep; 7(5):348-53. PubMed ID: 3778994 [TBL] [Abstract][Full Text] [Related]
51. Competitive adsorption of fibrinogen and albumin and blood platelet adhesion on surfaces modified with nanoparticles and/or PEO. Nonckreman CJ; Fleith S; Rouxhet PG; Dupont-Gillain CC Colloids Surf B Biointerfaces; 2010 Jun; 77(2):139-49. PubMed ID: 20171850 [TBL] [Abstract][Full Text] [Related]
52. Phagocytosis of monosize polystyrene-based microspheres having different size and surface properties. Ayhan H; Tuncel A; Bor N; Pişkin E J Biomater Sci Polym Ed; 1995; 7(4):329-42. PubMed ID: 7495763 [TBL] [Abstract][Full Text] [Related]
53. Preparation of sterically stabilized human serum albumin nanospheres using a novel Dextranox-MPEG crosslinking agent. Lin W; Coombes AG; Garnett MC; Davies MC; Schacht E; Davis SS; Illum L Pharm Res; 1994 Nov; 11(11):1588-92. PubMed ID: 7532861 [TBL] [Abstract][Full Text] [Related]
54. Nonspecific-adsorption behavior of polyethylenglycol and bovine serum albumin studied by 55-MHz wireless-electrodeless quartz crystal microbalance. Ogi H; Fukunishi Y; Nagai H; Okamoto K; Hirao M; Nishiyama M Biosens Bioelectron; 2009 Jun; 24(10):3148-52. PubMed ID: 19394213 [TBL] [Abstract][Full Text] [Related]
55. Development and characterization of glutathione-conjugated albumin nanoparticles for improved brain delivery of hydrophilic fluorescent marker. Patel PJ; Acharya NS; Acharya SR Drug Deliv; 2013; 20(3-4):143-55. PubMed ID: 23734981 [TBL] [Abstract][Full Text] [Related]
56. In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres. Neal JC; Stolnik S; Schacht E; Kenawy ER; Garnett MC; Davis SS; Illum L J Pharm Sci; 1998 Oct; 87(10):1242-8. PubMed ID: 9758684 [TBL] [Abstract][Full Text] [Related]
57. Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration. Wang G; Kucharski C; Lin X; Uludağ H J Drug Target; 2010 Sep; 18(8):611-26. PubMed ID: 20158316 [TBL] [Abstract][Full Text] [Related]
58. Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. Nagayama S; Ogawara K; Fukuoka Y; Higaki K; Kimura T Int J Pharm; 2007 Sep; 342(1-2):215-21. PubMed ID: 17566676 [TBL] [Abstract][Full Text] [Related]
59. Adsorption of bovine serum albumin on nano and bulk oxide particles in deionized water. Song L; Yang K; Jiang W; Du P; Xing B Colloids Surf B Biointerfaces; 2012 Jun; 94():341-6. PubMed ID: 22405471 [TBL] [Abstract][Full Text] [Related]
60. Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution. Ogawara K; Yoshida M; Higaki K; Kimura T; Shiraishi K; Nishikawa M; Takakura Y; Hashida M J Control Release; 1999 May; 59(1):15-22. PubMed ID: 10210718 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]